Status:
COMPLETED
Glycemic Control Based on Serum Fructosamine Concentration vs. hemoglobinA1c (HbA1c) in Diabetic Patients
Lead Sponsor:
Ohio State University
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
Diabetes mellitus is associated with negative outcomes in patients undergoing surgery. Blood sugar levels are monitored by measuring a values that include but are not limited to hemoglobin A1c, capill...
Detailed Description
This study aims to compare the predictive capacity of both fructosamine and HbA1c on preoperative basal glucose level, as well as adverse events (cardiovascular events, surgical site infection, and mo...
Eligibility Criteria
Inclusion
- Male or female patients able to consent.
- Patients with either Type I or Type II diabetes mellitus (DM)
- Patients undergoing non-cardiac surgeries under general anesthesia
- ≥ 18 years of age
Exclusion
- Inability to read, understand or sign the consent form
- End-stage renal disease
- Special populations (Incarcerated individuals, pregnant female patients)
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04079660
Start Date
February 1 2021
End Date
February 1 2021
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States, 43210